| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-09 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |